EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway

Yifan Wu, Yuanyuan Xv, Limei Zhao, Ziqi Zhou iD, Miaomiao Wang, Jima Xi, Ying Liming, Jianling Gao, Bingqing Deng, Dong Zheng iD

Physiological Reports · 2025

DOI: 10.14814/phy2.70162 ↗

At a glance

Journal article in Physiological Reports, 2025. Written by Yifan Wu and 9 co-authors. Institution: Department of Pathology and Pathophysiology, Medical College of Soochow University, Suzhou, Jiangsu, China. Major MEDLINE topics: Cisplatin, Phosphotransferases (Alcohol Group Acceptor), Signal Transduction. Cited 1 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China (NSFC).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Cisplatin is a widely used anticancer drug, but its accumulation in renal tubular epithelial cells (TECs) can cause acute kidney injury. Phosphoseryl‐tRNA kinase (PSTK) is an intermediate product produced under oxidative stress conditions. This study aimed to elucidate whether PSTK could protect TECs and its possible mechanisms. We found that PSTK levels decreased after cisplatin treatment, but PSTK overexpression using lentivirus vectors protected TEC viability. Overexpression of PSTK increased selenoprotein concentrations and reduced intracellular ROS levels. Additionally, PSTK overexpression inhibited the BAX/BCL2/Caspase 3 pathway after cisplatin stimulation, suggesting its potential role in preventing cell apoptosis. Taken together, this study suggests that PSTK could protect TEC viability from cisplatin‐induced injury, possibly by inhibiting mitochondrial apoptosis. The study is significant for developing therapeutic strategies that could manipulate PSTK to delay AKI progression.

Subjects

MeSH terms (MEDLINE)

CisplatinPhosphotransferases (Alcohol Group Acceptor)Signal Transductionbcl-2-Associated X ProteinCaspase 3Cell LineEpithelial CellsKidney TubulesOxidative StressProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesSelenoproteinsHumans

Author keywords

AKIPSTKapoptosiscisplatinoxidative stress

Substances

bcl-2-Associated X ProteinCaspase 3CisplatinPhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesSelenoproteins

Authors and institutions

  • Department of Pathology and Pathophysiology, Medical College of Soochow University, Suzhou, Jiangsu, China.
  • Department of Thoracic Surgery, School of Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • School of Biology & Basic Medical Sciences, Medical College of Soochow University, Suzhou, Jiangsu, China.
  • Department of Oncology, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Liangxi Taihu Hospital of Traditional Chinese Medicine, Wuxi, Jiangsu, China.
  • National Heart and Lung Institute Imperial College London, London, UK.

ORCID profiles: Ziqi Zhou, Dong Zheng

Funding

  • National Natural Science Foundation of China (NSFC)

Cite

APA

Wu, Y., Xv, Y., Zhao, L., Zhou, Z., Wang, M., Xi, J., Liming, Y., Gao, J., Deng, B., & Zheng, D. (2025). PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway. Physiological Reports. https://doi.org/10.14814/phy2.70162

Vancouver

Wu Y, Xv Y, Zhao L, Zhou Z, Wang M, Xi J, et al. PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway. Physiological Reports. 2025. doi:10.14814/phy2.70162

BibTeX
@article{Wu2025,
  author = {Wu, Yifan and Xv, Yuanyuan and Zhao, Limei and Zhou, Ziqi and Wang, Miaomiao and Xi, Jima and Liming, Ying and Gao, Jianling and Deng, Bingqing and Zheng, Dong},
  title = {PSTK exerts protective role in cisplatin‐tubular cell injury via BAX/BCL2/Caspase3 pathway},
  journal = {Physiological Reports},
  year = {2025},
  doi = {10.14814/phy2.70162}
}
Start for free →